Isofluran Baxter (Isoflurane)

Isoflurane works by enhancing the activity of the GABA_A receptor, which increases inhibitory neurotransmission in the brain. At the same time, it suppresses excitatory signals through NMDA receptors, leading to overall central nervous system depression, loss of consciousness, and muscle relaxation required for anesthesia.

The specific dose of Isofluran Baxter is determined by the prescribing anesthesiologist based on the patient’s age, weight, health status, and the type of surgery. Administration is typically performed via a calibrated vaporizer that delivers a precise concentration of the inhalation solution.

Safety data for Isofluran Baxter during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Isofluran Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Isofluran is comparable to other volatile agents such as sevoflurane and desflurane. It generally offers a slightly slower onset and recovery than sevoflurane but provides stable hemodynamic control and is less expensive. Desflurane has a faster onset but may cause airway irritation, whereas Isofluran balances cost and efficacy for many surgical settings.

Isofluran Baxter should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture, and extreme temperature fluctuations. Ensure that handling follows standard safety protocols for volatile anesthetic liquids.

Isofluran Baxter is administered by inhalation using a calibrated vaporizer attached to the patient’s breathing circuit. The anesthesiologist adjusts the vaporizer setting to achieve the desired concentration of the anesthetic gas, delivering it through the airway while continuously monitoring the patient’s vital signs.

The most serious risks include malignant hyperthermia, a rare but life‑threatening hypermetabolic reaction, and severe hypotension that can compromise organ perfusion. Other critical concerns are cardiac arrhythmias, hepatic toxicity, and rare cases of anaphylaxis, all of which require immediate medical intervention.

Isofluran Baxter should be avoided in individuals with a known hypersensitivity to isoflurane or any of its components, patients with a history of malignant hyperthermia susceptibility, and those with severe uncontrolled cardiovascular or respiratory disease where the drug’s depressant effects could be hazardous.